Modified GHRH analogue / Material & research guide
Tesamorelin
Tesamorelin is a modified GHRH analogue. Its identity is distinct from sermorelin and from intact growth hormone.
Catalog specification — select for your inquirySelected: 2 mg × 10 vials
Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.
Material profile
About the material
Tesamorelin is a modified GHRH analogue. Its identity is distinct from sermorelin and from intact growth hormone.
For Tesamorelin, the useful starting point is the material identity—not the broad research category. Compare the complete name and supplied form with the reference used by your laboratory.
Confirm the modification, complete sequence specification and counter-ion. For a combination request, state each component and amount separately.
Scientific context
Research context
Research using tesamorelin concerns that modified sequence and the study formulation. It does not authenticate this catalog supply or establish a use protocol.
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
The Journal of clinical endocrinology and metabolism · 2010 · PMID 20554713
Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.
Read the primary publication ↗Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
JAMA · 2014 · PMID 25038357
Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.
Read the primary publication ↗For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.
Catalog & quotation
Specifications
| Catalog material | Tesamorelin |
|---|---|
| Material class | Modified GHRH analogue |
| Listed options | 2 mg × 10 vials 5 mg × 10 vials 10 mg × 10 vials 20 mg × 10 vials |
| Identity / supplied form | Confirm the modification, complete sequence specification and counter-ion. For a combination request, state each component and amount separately. |
| Identity, purity and content | Request the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements. |
| Storage / stability | Follow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed. |
Evidence for the offered material
Documents
Confirm document availability for the actual material and lot. A catalog purity target or packaging label is not a released batch result.
Confirm the modification, complete sequence specification and counter-ion. For a combination request, state each component and amount separately.
Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.
Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.
Before you inquire
Questions
What differentiates this request from a sermorelin request?
Confirm the modification, complete sequence specification and counter-ion. For a combination request, state each component and amount separately.
What should my Tesamorelin inquiry include?
Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.
Does the catalog image confirm the selected specification?
No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.
Does a paper or an existing report validate every future batch?
No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.
Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.
Build your Tesamorelin inquiry.
Include the material, amount and evidence your laboratory needs to review.